3[1]Shimada K,Ajani JA.Adjuvant therapy for gastric carcinoma patients in the past 15 years[J].Cancer,1999,86(9):1657-1668.
4[2]Saito H,Tsujitani S,Oka S,et al.The expression of transforming growth factor-β 1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma[J].Cancer, 1999,86(8):1455-1462.
5[3]Shimomura K,Manda T,Mukumoto S,et al.Ricombinant human tumor necrosis factor-alpha:thrombus formation is a cause of anti-tumor activity[J].Int J Cancer, 1988,41(2):243-247.
6[4]Stoelcker B,Ruhland B,Hehlgans T,et al.Tumor necrosis factor induces tumor necrosis via tumor necrosis factor receptor type 1-expressing endothelial cells of the tumor vasculature[J].Am J Pathol, 2000,156(4):1171-1176.
7[5]Ruegg C,Yilmaz A,Bieler G,et al.Evidence for the involvement of endothelial cell integrin alpha Vbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-Gamma[J].Nature Med, 1998,4(3):408-414.
8[6]Murugesan G,Rani MR,Ransohoff RM,et al.Endothelial cell expression of monocyte chemotactic protein-1,tissue factor,and thrombomodulin on hydrophilic plasma polymers[J].J Biomed Mater Res, 2000,49(3):396-408.
